{"symbol": "CRIS", "companyName": "Curis Inc.", "exchange": "NASDAQ Global Market", "industry": "Biotechnology", "website": "http://www.curis.com", "description": "Curis Inc is a biotechnology company engaged in developing and commercializing drug candidates for the treatment of human cancers. Its pipeline products include CUDC-907, CA-170, CA-4948, CA-327, and Erivedge.", "CEO": "James E. Dentzer", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}